Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and lowers the price target from $66 to $60.
Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and lowers the price target from $66 to $60.